Developing regions vs Kuwait: Proportion of the target population who received a 3rd dose of
Developing regions
66.0%
in 2024
Kuwait
96.0%
in 2024
Developing regions rank
12th
Kuwait rank
15th
Proportion of the target population who received a 3rd dose of over time
- Developing regions
- Kuwait
How they compare
Kuwait currently reports 96.0% against 66.0% in Developing regions, a difference of 30.0%.
That makes Kuwait's figure about 1.5 times Developing regions's.
Across all 17 years both countries report, Kuwait has been ahead every year.
Developing regions ranks 12th and Kuwait ranks 15th of 19 groups.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Developing regions | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 99.0% | 97.5% | Kuwait |
| 2010s | 28.4% | 97.0% | 68.6% | Kuwait |
| 2020s | 56.4% | 96.8% | 40.4% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developing regions or Kuwait?
- Kuwait, at 96.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developing regions and Kuwait?
- 30.0%, with Kuwait ahead.
- How many years of comparable data are there for Developing regions and Kuwait?
- 17 years are reported by both, from 2008 to 2024.
- How do Developing regions and Kuwait rank globally for proportion of the target population who received a 3rd dose of?
- Developing regions ranks 12th and Kuwait ranks 15th of 19 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.